Optimizing Treatment Approaches in Patients with HER2+ Metastatic Breast Cancer: Insights From Experts at the Dana Farber Cancer Institute

Centering discussion on several patient cases, expert oncologists work together to review the evolving treatment landscape of HER2+ breast cancer with a focus on brain metastases.